Mitomycin C, 5-fluorouracil, leucovorin, and oxaliplatin as a salvage therapy for patients with cisplatin-resistant advanced gastric cancer: a phase I dose escalation trial.
about
Mitomycin C in the treatment of gastrointestinal tumours: recent data and perspectives.Identification of consensus genes and key regulatory elements in 5-fluorouracil resistance in gastric and colon cancer.The safety and efficacy of fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) combination in the front-line treatment for patients with advanced gastric or gastroesophageal adenocarcinoma: phase II trial.Biweekly fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) for patients with metastatic adenocarcinoma of the stomach or esophagogastric junction: a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie.
P2860
Mitomycin C, 5-fluorouracil, leucovorin, and oxaliplatin as a salvage therapy for patients with cisplatin-resistant advanced gastric cancer: a phase I dose escalation trial.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Mitomycin C, 5-fluorouracil, l ...... phase I dose escalation trial.
@ast
Mitomycin C, 5-fluorouracil, l ...... phase I dose escalation trial.
@en
type
label
Mitomycin C, 5-fluorouracil, l ...... phase I dose escalation trial.
@ast
Mitomycin C, 5-fluorouracil, l ...... phase I dose escalation trial.
@en
prefLabel
Mitomycin C, 5-fluorouracil, l ...... phase I dose escalation trial.
@ast
Mitomycin C, 5-fluorouracil, l ...... phase I dose escalation trial.
@en
P2093
P2860
P356
P1433
P1476
Mitomycin C, 5-fluorouracil, l ...... phase I dose escalation trial.
@en
P2093
Akin Atmaca
Anne Kerber
Antje Neumann
Claudius Dechow
Eckhart Weidmann
Elke Jäger
Ernst Reitsamer
Joerg Thomas Hartmann
Salah-Eddin Al-Batran
Sebastian Schmidt
P2860
P356
10.1159/000097768
P577
2007-01-26T00:00:00Z